Close Menu

NEW YORK – A research study has shown that genetic testing to help guide medication decisions after a heart procedure is non-inferior to standard treatment.

Led by senior author Jurriën ten Berg of St. Antonius Hospital in Nieuwegein, the Netherlands, researchers conducting the POPular Genetics study compared a genotype-guided strategy of selecting anti-platelet medication to accompany primary percutaneous coronary intervention (PCI) with standard treatment of one of two platelet inhibitors.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.